1.Characteristics, management, and predictors of 6-month mortality in very elderly patients admitted for decompensated heart failure.
Prado SALAMANCA-BAUTISTA ; Rocío RUIZ-HUESO ; Irene BRAVO-CANDELA ; Miriam ROMERO-CORREA ; Ana Belkis PORTO-PÉREZ ; Luis Enrique CAJAMARCA-CALVA ; Miguel OTERO-SOLER ; Carlos Jiménez-de JUAN ; Aída GIL-DÍAZ ; Carmen ALEMÁN-LLANSÓ ; Javier ABELLÁN-MARTÍNEZ ; Francesc FORMIGA
Journal of Geriatric Cardiology 2025;22(9):802-811
BACKGROUND:
Patients aged 85 years or older admitted for heart failure (HF) have increased enormously due to improved survival in this disease. However, few studies assess the characteristics, treatments, and prognosis of very elderly patients admitted for acute HF.
METHODS:
This study is a retrospective analysis of the EPICTER registry, that included patients admitted for acute HF in 74 Spanish hospitals. For this analysis, a total of 1887 patients were included and divided into 2 groups: 85 years or older (very elderly, 680 patients) and those under 85 years.
RESULTS:
Compared to patients < 85 years, very elderly patients were more frequently women, had more hypertension and disease cerebrovascular disease, and less presence of chronic obstructive pulmonary disease (COPD), diabetes, and acute myocardial infarction. There were no differences in symptoms, except for delirium, significantly more common in very elderly patients. Management of these patients was more conservative and died more than the younger ones (41% vs. 25%, P < 0.001). The predictor variables of mortality in very elderly patients were the presence of COPD and peripheral arterial disease, delirium, and estimated survival of less than 6 months assessed by the physician in charge of the patient care.
CONCLUSION
Very elderly patients admitted for HF differ from younger ones in comorbidities, management, and symptoms, and have higher mortality. The presence of delirium, peripheral arterial disease, and COPD worsen the prognosis in these patients and can help to adapt the therapeutic effort and place emphasis on adequate symptom control.
2.Spit or swab? The diagnostic accuracy of saliva-based testing as a SARS-CoV-2 surveillance tool
Raymundo Lo, Farrah Kristine Santiago ; Grig Misiona ; Melani Sionzon ; Danielle Anne Gonong ; Jill Jaime ; Jan Roman Ayco ; Aquiles Joseph Lira ; Erik Francis Rarugal ; Jon Carlo Crisostomo ; Manuel Bautista ; Kenneth Chrysostom Ibarra ; Eunice Jane Ciriaco ; Arielle Trish Zamora ; Kimberly Abundo ; Emmylou Tarnate ; Jonathan Nario ; an Joseph Hernandez ; Kathleen Mae Montes ; Anabella Recio
Philippine Journal of Pathology 2022;7(2):13-22
Background:
Nasopharyngeal swab/oropharyngeal swab (NPS/OPS) qRT-PCR is the gold standard for detecting SARS-CoV-2. However, it has its own limitations including cost and invasiveness. As an alternative, individual qRT-PCR testing of saliva samples was validated and shown to be comparable in sensitivity and specificity with NP-OP qRT-PCR. To further maximize its utility, the researchers wish to explore antigen and pooled testing methods.
Objective:
The study aimed to evaluate the diagnostic accuracy of detecting SARS-CoV-2 infection using saliva-based pooled qRT-PCR and rapid antigen test compared with individual saliva qRT-PCR.
Methodology:
In this retrospective cross-sectional study, saliva specimen from individuals aged 18 years old and above from the outpatient specimen collection station at the Philippine Children’s Medical Center were tested individually using qRT-PCR (Mag-bind RNA Extraction Kit/MACURA, Allsheng Extraction Machine, Sansure PCR kit, and MA-600 Sansure Biotech). Non-probability convenience sampling was utilized. Based on the individual results, pools of five (5) individual specimens, which includes one (1) positive sample were tested with qRT-PCR for sensitivity. DNK-2150-1S Dynamiker SARS-CoV-2 Ag Rapid Test (Dynamiker Biotechnology Co., Ltd., Tianjin, China) was also used to test individual saliva specimens. . Out of 196 individual saliva specimens, 73 were detected to have SARS-COV-2 by qRT-PCR, while the remaining 123 were negative. Compared with the individual saliva qRT-PCR, rapid antigen tests done showed sensitivity of 46.58% (95% CI 35.13%, 58.02%), specificity of 86.18% (95% CI 80.08%, 92.28%), positive and negative predictive value of 66.67% (95% CI 53.71%, 79.60%) and 73.10% (95% CI 65.89%, 80.32%) respectively. Based on the results of individual saliva-based qRT-PCR, 62 pools were tested and showed sensitivity of 98.39% (95% CI 91.34%, 99.96%).
Conclusion and Recommendation
Pooled saliva-based testing for SARS-CoV-2 is comparable with individual saliva-based rapid antigen testing. The use of rapid antigen testing is less sensitive and less specific compared with qRT-PCR consistent with prior reports. Additional studies are recommended to determine optimal conditions for testing.
SARS-CoV-2
;
COVID-19


Result Analysis
Print
Save
E-mail